+

WO2001066687A1 - Dispositifs monoblocs d'hybridation d'acide nucleique - Google Patents

Dispositifs monoblocs d'hybridation d'acide nucleique Download PDF

Info

Publication number
WO2001066687A1
WO2001066687A1 PCT/US2000/023438 US0023438W WO0166687A1 WO 2001066687 A1 WO2001066687 A1 WO 2001066687A1 US 0023438 W US0023438 W US 0023438W WO 0166687 A1 WO0166687 A1 WO 0166687A1
Authority
WO
WIPO (PCT)
Prior art keywords
association
ofthe
nucleic acid
porous
probe
Prior art date
Application number
PCT/US2000/023438
Other languages
English (en)
Inventor
Michael Hogan
Thomas Powdrill
Bonnie Iverson
Yuri Y. Belosludtsev
Inna Y. Belosludtsev
Original Assignee
Genometrix Genomix, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genometrix Genomix, Inc. filed Critical Genometrix Genomix, Inc.
Priority to AU2000269393A priority Critical patent/AU2000269393A1/en
Publication of WO2001066687A1 publication Critical patent/WO2001066687A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means

Definitions

  • the present invention generally relates to the fields of molecular biology and diagnostic medicine.
  • the invention relates to "association" devices and methods for enhanced and selective association or binding between nucleic acids, such as DNA or RNA, or polypeptides, and an immobilized oligonucleotide or polypeptide probe.
  • nucleic acids such as DNA or RNA, or polypeptides
  • polypeptides such as DNA or RNA, or polypeptides
  • immobilized oligonucleotide or polypeptide probe such as DNA or RNA, or polypeptides
  • association that can be used for, e.g., nucleic acid-based diagnostic tests, isolation of nucleic acids or polypeptides, and the like.
  • nucleic acids The ability to hybridize nucleic acids with adequate sensitivity and selectivity is strongly dependent on a number of physical chemistry considerations and has been a subject of considerable attention. Of primary importance, is the electrostatic nature of nucleic acids and the need for bulk solution cations to screen the negative charges ofthe phosphate groups on the backbone, allowing hydrogen bonding to occur between the two negatively charged polyelectrolytes. Electrostatics play a critical role in vivo also, being a primary determinant in cellular functions such as replication, recombination, transcription, chromatin structure, packing and ligand binding.
  • PNAs peptide nucleic acids
  • the present invention provides devices and methods to improve the specificity and kinetics ofthe association, e.g. hybridization, of nucleic acids in solution to immobilized nucleic acids (e.g., probes).
  • the probes can be immobilized on any surface in any configuration, such as, e.g., microtiter well plates, array-based hybridization detection devices, porous substrates (beads, membranes), and the like.
  • the invention provides significant increases in the kinetics, sensitivity and discrimination power of nucleic acid- based (e.g., DNA and RNA-based) and polypeptide-based biosensors and related hybridization techniques.
  • the present invention is useful in modern molecular techniques using large array-based strategies.
  • oligonucleotide probe molecules are bound (covalently or non-covalently attached) to a device-compatible substrate, often in a miniaturized format.
  • the exploitation ofthe "smart" or “tunable” surfaces of the invention upon which to perform association or hybridization is imminently useful in maximizing the information output of modern nucleic acid detection or isolation devices.
  • the present invention for the first time uses the active participation of a substrate material upon which oligonucleotide probes are specifically tethered in nucleic acid association/ hybridization reactions.
  • the invention provides association devices for the detection and/or isolation of nucleic acids in a test sample.
  • the association can by convention Watson- Crick base pairing, Hoogsteen-based double or triple helix formation, reverse Hoogsteen ydrogen on ng nteract ons, an t e e, as scusse n eta e ow.
  • one embodiment ofthe present invention provides an association/ hybridization device for detecting a target area in a nucleic acid, e.g., a DNA, a cDNA or a RNA, or analogs or mimetics thereof.
  • an association/ hybridization device comprising an oligonucleotide probe, and a solid substrate, said solid substrate having a support or solid surface with a "tunable" positive, neutral or negative net electrostatic field.
  • the "tunable" support surface comprises an association/ hybridization surface accessible for linking the oligonucleotide probe to the solid substrate or association surface.
  • the oligonucleotide probe can be linked to the association/ hybridization surface ofthe solid substrate at a distance of no more than about 100 angstroms.
  • the oligonucleotide probe is linked to the hybridization surface by a covalent linkage or a slowly reversible, non-covalent linkage.
  • the distance is no more than about 75 angstroms, 60 angstroms, 50 angstroms, 30 angstroms, or about 20 angstroms.
  • the support surface ofthe device has a negative electrostatic field, i.e., a net negative field density.
  • This can include support surfaces having, e.g., a layer of negatively charged protein film, or any composition which can switch the charge ofthe electrostatic field in the range of about pH 5 to about pH 8 to about pH 10.
  • the switch can be, e.g., from positive or neutral during association to negative during washing.
  • the support surface or hybridization surface can be composed of compositions where the electrostatic field (the net charge density ofthe surface ofthe device) is more cationic (positive net charge density) during hybridization and more anionic (negative net charge density) during washing.
  • the support surface or association (e.g., a hybridization) surface ofthe device comprises a composition having a pi in a range of between about pi 5 to about pi 10.
  • the support surface or association (e.g., hybridization) surface ofthe device has a net positive (cationic) charge density (i.e., net positive electrostatic charge).
  • a net positive (cationic) charge density i.e., net positive electrostatic charge.
  • the device for the "wash" phase, is adjusted to a point at least just above (basic to) the pi ofthe composition (by, e.g., adjusting the pH ofthe association/hybridization solution), then the support surface or association (e.g., hybridization) surface ofthe device has a net negative (anionic) charge density (i.e., net negative electrostatic charge).
  • the support surface or association surface can be composed of compositions where the electrostatic field is cationic or neutral at about pH 5 to about pH 6, at about pH 5 to about pH 7, at about pH 5 to about pH 8, at about pH 5 to about pH 9, or at about pH 5 to about pH 10; and negatively charged at about pH 7 to about pH 8, at about pH 7 to about pH 9, or at about pH 7 to about pH lO.
  • association/hybridization surface can be streptavidin, imidazole, imidazole derivatives, carboxylic acid, histidine, histidine derivatives, citrate or other groups, including those with a pK value near neutrality.
  • the association conditions are adjusted to be below 5.5 (with, however, a practical lower range of about pH 4.5), and wash conditions are adjusted to be above 5.5 (with a practical upper limit of about pH 10).
  • the association/ hybridization surface is streptavidin and the oligonucleotide probe comprises biotin (e.g., is modified to include biotin); in this example, the oligonucleotide probe is linked to the hybridization surface by non-covalent interaction ofthe biotin with the streptavidin.
  • Oligonucleotide probes used in the invention ca be conjugated or modified by any first compound having an affinity for a second compound which is attached (covalently or non-covalently) to the association surface or the solid support surface ofthe device.
  • the association/hybridization surface can be arginine, an arginine derivative, salmine Al, a salmine A 1 -probe chimera linked to the support surface, any amino acid, an amino acid ester or a mixture of amino acids and/or amino acid esters.
  • Primary amine groups have a pi of 10.
  • the device can be adjusted to a pH anywhere below pH 10 for association conditions on the solid support surface (e.g., the "association surface") to be a net positive charge density; and pH 10 or higher for wash conditions.
  • the association/ hybridization surface also can be comprised of two or more different compounds, e.g., those listed herein.
  • the solid support surface ofthe device can be any composition.
  • the support surface can be metal, polyvinyl, polystyrene, polypropylene or polyester.
  • the association/ hybridization surface can be a carboxylic acid surface placed on the support surface; where the oligonucleotide probe has been modified to include an amino group; and the modified probe is covalently linked to the association/ hybridization surface.
  • the support surface is polystyrene; the association/ hybridization surface is streptavidin; the oligonucleotide probe has been modified to include biotin; and the oligonucleotide probe is linked to the hybridization surface by non-covalent interaction ofthe biotin with the streptavidin.
  • the support surface is glass and the oligonucleotide probe and glass form a substrate surface-probe complex by linking the probe to the substrate surface by an epoxysilane linkage to a terminal amine modification, and the substrate surface-probe complex forms an effective association/ hybridization surface.
  • Another specific embodiment includes a method for detecting single base difference in a target area of a strand of DNA or RNA comprising mixing a nucleic acid with an association/ hybridization device ofthe invention with immobilized oligonucleotide probes containing (with sequence complementary to) the target area to be detected; allowing sufficient time for the target area to associate/ hybridize to the device; altering the environment ofthe oligonucleotide probe and DNA or RNA target area to remove non- hybridized DNA or RNA; and detecting the DNA or RNA hybridized to the association/ hybridization device.
  • the invention provides a method for promoting the association (e.g., hybridization) of a nucleic acid to an immobilized nucleic acid probe comprising the following steps: (a) providing a test sample comprising a nucleic acid; (b) providing a device comprising an oligonucleotide probe linked to a solid substrate; wherein the solid substrate comprises a substrate surface and an association surface; wherein the association surface comprises a composition having a pi in a range of between about pi 5 to about pi 10; and (c) contacting the test sample of step (a) with the association device of step (b) under conditions that induce the substrate surface or association surface to have a net positive (cationic) charge density.
  • the device can be designed such that the charged surface (e.g., the net positive (cationic) charge density) is close enough to the oligonucleotide probe (the area in which the association/ hybridization with nucleic acid sample will occur) to measurably influence the kinetics or specificity of association.
  • the distance is between the oligonucleotide probe and the positively charged surface is at or no more than about 100 angstroms, about 50 angstroms, about 30 angstroms, or about 20 angstroms. However, depending on the composition ofthe association surface (discussed below) and the degree of charge field generated, or desired, the distance can be greater or smaller.
  • the substrate surface or the association surface ofthe device ofthe invention comprise different compositions (or mixtures thereof).
  • the device can be designed to have any net pi, and, as it is the pi which determines when the device will have a net positive or a net negative charge field under particular acidic or basic (pH) conditions, the device can be designed to have a net positive or negative charge field under specific pH conditions.
  • Conditions that induce the substrate surface or association surface to have a net positive (cationic) charge density comprise a pH below the pi ofthe composition.
  • Conditions that induce the substrate surface or association surface to have a net negative (anionic) charge density comprise a pH above the pi ofthe composition.
  • the device has a net positive or a negative charge.
  • the device itself substantively influences the kinetics and specificity of association/ hybridization.
  • the device is "tunable," i.e., can have either a positive or a negative net charge density on its support or association surface
  • the device ofthe invention can influence the kinetics and/or specificity of both sample nucleic acid:probe association (as in a hybridization step) and disassociation (as in a washing step).
  • the association conditions can further comprise no salt or low salt conditions.
  • Low salt conditions comprise any set of conditions wherein the sodium ion (or equivalent ion) concentration is less than seen under physiologic conditions.
  • low salt conditions can comprise less than about 100 mM, about 75 mM, about 50 mM, about 25 mM, about 20 mM, about 15 mM, or about 5 mM, or about 2 mM sodium or equivalent cation.
  • the salt can be sodium chloride, potassium chloride, sodium phosphate, or equivalents.
  • low salt conditions can comprise about 100 mM, about 50 mM, about 30 mM, or about 20 mM, about 15 mM, or about 5 mM, or about 2 mM sodium phosphate.
  • the contacting step is under conditions equivalent to an aqueous solution at about pH 4.5 to about 5.4 comprising about 0.1% to 0.3% detergent and about 2 mM sodium phosphate (typically, this is when the device association surface has a net pi of about pi 5.5 to 6, e.g., when the surface comprises streptavidin).
  • the substrate surface is pre-treated (before the hybridization step) with an aqueous solution of detergent and neutral polymer.
  • the detergent can be anionic, cationic, zwitterionic, or a combination thereof, e.g., Tween, NP-40, Triton X-100, CHAPS, and the like.
  • the pre-treatment solution can be about 0.1% to about 0.3% detergent and about 2X to about 5X Denhardts's solution.
  • the methods of invention can be practiced and the device can be used at any temperature. However, one practical advantage ofthe invention is that it can be practiced at temperatures at or approximately room temperature or about 22°C to 25°C.
  • the kinetics of association between the oligonucleotide probe and the nucleic acid in the test sample are at least ten fold more rapid than the kinetics of association under conditions wherein the substrate surface or association surface has a neutral or net negative charge density (including conditions at room temperature).
  • the probes ofthe invention can comprise any nucleotide, as defined in its broadest sense, including, e.g., synthetic variants of DNA and RNA; single stranded and double stranded probes, linear, circular or "stem-looped" structures; DNA:DNA, RNA:RNA or chimeric structure (e.g., mixed linear, DNA:RNA or other chimerics).
  • the probes ofthe invention can be of any length; e.g., oligonucleotides used as probes in the devices of the invention can have a length of at least about 11 to about 20 residues in length, or to about 30 residues, 40 residues, 50 residues, 75 residues, 100 residues or greater in length.
  • the device can comprise any number of probes; in one embodiment the device ofthe invention comprises a plurality of immobilized oligonucleotide probes. Devices with pluralities of immobilized probes have been called “arrays" or “DNA chips.” As discussed in detail below, the "tunable" surfaces ofthe invention can be incorporated into any known "array- based" nucleic acid association/ hybridization device, or combination, or variation thereof.
  • the association surface can comprise a variety of compounds or mixture thereof; for example, a composition comprising the association surface can comprise streptavidin, which has a pi of about 5.5. In this embodiment (with streptavidin), the association (e.g., hybridization step) conditions can comprise a pH of below 5.5 to set a net cationic charge density to the device's surface.
  • the composition can comprise a primary amine group having a pi at about 10; thus, under association conditions comprising a pH of below 10, the net charge density of the surface ofthe device is negative.
  • the composition can comprise a peptide having a pi at about neutrality or in the range of about pH 6.7 to about pH 10.
  • the composition comprising a primary amine group can be an amino silane, a polylysine, or an organic polyamine, or equivalents thereof.
  • the peptide can be, e.g., polyhistidine, poly-(his) 2 (gly) t , or poly-(his) 2 (asp) ⁇ , or equivalents thereof.
  • the composition can comprises an organic molecule having a pi at about
  • the organic molecule can be, e.g., an imidazole derivative, or equivalents thereof.
  • the association ofthe nucleic acid in the sample to the nucleic acid probe can comprise, e.g., Watson-Crick base pairing, Hoogstein based double or triple helix formation or reverse
  • the probes ofthe invention can be either single stranded, double stranded, stem-loop configured, and the like.
  • the invention also provides methods for detecting association of a nucleic acid in a sample to a nucleic acid probe or purifying a nucleic acid from a sample comprising the following steps: (a) providing a sample comprising a nucleic acid; (b) providing an association device comprising an oligonucleotide probe linked to a solid substrate; wherein the solid substrate comprises a substrate surface and an association surface; wherein the association surface comprises a composition having a pi in a range of between about pi 5 to about pi 10, (c) contacting the test sample of step (a) with the association device of step (b) under conditions that induce the substrate surface or the association surface to have a net positive (cationic) charge density; (d) removing the test sample nucleic acid not associated to the probe of step (b) by washing; and, (e) detecting nucleic acid remaining associated to the nucleic acid probe after step (d).
  • the device ofthe invention can be designed such that the net positive (cationic) charge density is close enough to the oligonucleotide probe to measurably influence the kinetics or specificity of association.
  • the distance between the probe and the charged surface ofthe device can be about 100 angstroms, about 50 angstroms, about 30 angstroms, or about 20 angstroms, or, if appropriate, greater or lesser distances.
  • the association conditions of further comprise no salt or low salt conditions.
  • low salt conditions comprise any set of conditions wherein the sodium ion (or equivalent ion) concentration is less than seen under physiologic conditions.
  • low salt conditions can comprise, e.g., less than about 100 mM, about 75 mM, about 50 mM, about 25 mM, about 20 mM, about 15 mM, or about 5 mM, or about 2 mM sodium or equivalent cation.
  • the salt can be sodium chloride, potassium chloride, sodium phosphate, or equivalents.
  • the salt can also include any alkaline metal, e.g., (in addition to K+), Cs+, and equivalents, and other divalent cations, e.g., Mg++, and equivalents.
  • low salt conditions can comprise sodium phosphate or equivalent in these concentrations.
  • the contacting of step (c) e.g., the association step or hybridization step
  • the wash step can be accomplished in no more than about 30 seconds.
  • the contacting of step (c) and the washing step are both accomplished in no more than about 30 seconds.
  • conditions that induce the substrate surface or the association surface to have a net positive (cationic) charge density in the contacting of step (c) comprise conditions having a pH below the pi ofthe composition (ofthe association surface).
  • the washing step further comprises conditions which alter the association surface (from a positive net charge density) to induce a neutral or net negative (anionic) charge density.
  • These conditions can comprise a pH at or above the pi ofthe composition.
  • the composition can comprise streptavidin having a pi of about 5.5; and, the association step can be under conditions comprising a pH of below 5.5; and, the washing step can be under conditions above pH 5.5.
  • the composition can comprise a primary amine group having a pi at about 10.
  • the composition comprising the primary amine group can be selected from the group consisting of amino silane, polylysine, organic polyamines, or equivalents or mixtures thereof.
  • the association can be under conditions comprising a pH of below 10.
  • the washing step can be under conditions above pH 10, or, the washing step can comprise use of a wash buffer comprising a composition that neutralizes or induces a negative (anionic) charge density on the association (e.g., hybridization) surface.
  • the neutralizing composition in the wash step can comprise an anionic polymer, such as, e.g., oligo-aspartate, oligo-glutamate, polyvinyl sulfate, milk casein, or equivalent.
  • the neutralizing composition can also comprises a neutral polymer, such as, e.g., one or a mixture of neutral polymers, including, e.g., polyvinyl py ⁇ olidine, ficol or BSA.
  • the association ofthe nucleic acid in the test sample to the nucleic acid probe can comprise Watson-Crick base pairing, Hoogstein based double or triple helix formation, reverse Hoogsteen hydrogen bonding interactions, and the like.
  • the invention also provides methods for detecting a single base pair difference between a nucleic acid in a test sample and an oligonucleotide probe comprising the following steps: (a) providing a test sample comprising a nucleic acid; (b) providing an association device comprising an oligonucleotide probe linked to a solid substrate; wherein the solid substrate comprises a substrate surface and an association surface; wherein the association surface comprises a composition having a pi in a range of between about pi 5 to about pi 10, wherein the distance between the oligonucleotide probe and the composition is no more than about 100 angstroms; (c) contacting the test sample of step (a) with the association device of step (b) under conditions that induce the substrate surface or the association surface to have a net positive (cationic) charge density under no salt or low salt conditions; (d) altering the association surface to an anionic environment by changing the conditions to comprise a pH that induces a net negative (anionic) charge density to the association surface, or, a neutral
  • the invention also provides methods for detecting a single base pair difference between a nucleic acid in a test sample and an oligonucleotide probe comprising the following steps: (a) providing a test sample comprising a nucleic acid; (b) providing an association device comprising a plurality of immobilized oligonucleotide probes linked to a solid substrate comprising a polystyrene, wherein the solid substrate comprises a surface onto which a strepavidin has been immobilized, wherein the distance between the oligonucleotide probe and the positively charged surface is no more than about 100 angstroms; (c) contacting the test sample of step (a) with the association device of step (b) under no salt or low salt conditions and a pH of below 5.5; (d) washing the oligonucleotide probes with a buffer comprising conditions over pH 5.5; (e) removing the test sample nucleic acid not specifically associated with the probe of step (b) under the wash conditions of step
  • the oligonucleotides probes can be biotinylated and linked to the solid substrate by binding ofthe biotin to a high-affinity biotin binding ligand, e.g., strepavidin or avidin, anti-biotin antibody, or equivalents.
  • a high-affinity biotin binding ligand e.g., strepavidin or avidin, anti-biotin antibody, or equivalents.
  • the invention also provides method for making a hybridization device comprising an oligonucleotide probe linked to a solid substrate comprising the following steps: (a) providing a clean polystyrene surface or equivalent; (b) providing a biotinylated oligonucleotide probe; (c) providing a strepavidin tetramer; (d) contacting the biotinylated oligonucleotide probe of step (b) with the strepavidin tetramer of step (c) in an aqueous solution; (e) applying the aqueous solution of step (d) directly to the polystyrene surface of step (a); and, (f) incubating the probe-applied polystyrene of step (e) in a humid environment for a sufficient amount of time to allow stable absorption ofthe strepavidin to the polystyrene surface.
  • the ratio of biotinylated oligonucleotide probe to strepavidin tetramer in the solution can be about, e.g., four to one, about three to one, about two to one, or about one to one.
  • the aqueous solution can comprise about 20 mM sodium acetate or equivalent at a pH of about 5.5.
  • the application of solution can comprise depositing a plurality of solution microdeposits.
  • the microdeposits of solution can comprise, e.g., about 10 to about 50 nanoliters; or, a microdeposit solution fluid volume ranging between about 10 picoliters to about 100 nanoliters, between about 100 picoliters to about 50 nanoliter, or between about 1 nanoliter to about 20 nanoliters.
  • Association Devices comprising Porous Sold Substrates
  • the invention provides an porous association device comprising: a plurality of nucleic acid probes or polypeptide probes or a combination thereof linked to a solid substrate; wherein the solid substrate comprises a substrate surface comprising an external substrate surface and a plurality of internal pores, wherein the pores comprise a proximal end opening to the external surface to allow passage of fluid into a pore, and wherein the pore surfaces comprise an association surface; wherein the association surface comprises a charged surface comprising net positive (cationic) charge density under conditions comprising a pH lower than the pi ofthe association surface; wherein the association surface comprises a charged surface comprising a net negative charge density under conditions comprising at a pH higher than the pi ofthe association surface; and, wherein the distance between the nucleic acid (e.g., oligonucleotide) probe or the polypeptide probe and the charged association surface is no more than about 100 angstroms.
  • the nucleic acid e.g., oligonucleotide
  • the association device further comprises an aqueous solution comprising a pH lower than the pi ofthe association surface, thereby inducing a net positive (cationic) charge density on the association surface.
  • the net positive (cationic) charge density on the association surface can induce a net positive (cationic) charge density in the pore space of the device, thereby generating a thermodynamic partitioning equilibrium favorable to the movement of negatively charged molecules into the pore space from the aqueous solution outside ofthe pores and favorable to the movement of positively charged molecules out of the pore space.
  • the thermodynamic partitioning equilibrium is favorable to the movement of negatively charged DNA or RNA polynucleotides or negatively charged polypeptides into the pore space from the aqueous solution outside ofthe pores.
  • the net positive (cationic) charge density on the charged surface ofthe association surface can be at least about 10 10 or at least about 10 11 charges per square millimeter or a charge equivalent thereof.
  • the porous association device ofthe invention comprises an aqueous solution comprising a pH higher than the pi ofthe association surface thereby inducing a net negative (anionic) charge density on the association surface.
  • the net negative (anionic) charge density on the association surface induces a net negative (anionic) charge density in the pore space ofthe device, thereby generating a thermodynamic partitioning equilibrium favorable to the movement of positively charged molecules into the pore space from the aqueous solution outside ofthe pores and favorable to the movement of negatively charged molecules out ofthe pore space.
  • the thermodynamic partitioning equilibrium is favorable to the movement of negatively charged DNA or RNA polynucleotides or negatively charged polypeptides out ofthe pore space.
  • the net negative (anionic) charge density on the charged surface of association surface is at least about 10 10 or at least about 10 11 charges per square millimeter or a charge equivalent thereof.
  • the porous association surface comprises a streptavidin linked to an oligonucleotide or a polypeptide probe.
  • the streptavidin can be present on the association surface at a density of at least about 10° molecules, about 10 10 molecules, or about IO 11 molecules or about per square millimeter.
  • the porous association surface comprises a histidine or histidine derivative linked to an oligonucleotide or a polypeptide probe.
  • the histidine or histidine derivative can be present on the association surface at a density of at least about 10° molecules, about 10 10 molecules, or about IO 11 molecules per square millimeter.
  • the porous association surface comprises an imidazole or an imidazole derivative linked to an oligonucleotide or a polypeptide.
  • the imidazole or imidazole derivative can be present on the association surface at a density of at least about 10° molecules, about 10 10 molecules, or about 10 11 molecules per square millimeter.
  • the porous association surface comprises a citrate or citrate derivative linked to an oligonucleotide or a polypeptide probe.
  • the citrate or citrate derivative is present on the association surface at a density of at least about 10° molecules, about 10 10 molecules, or about 10 11 molecules per square millimeter.
  • the internal pores comprise a diameter of at least about 10 angstroms to about 1000 angstroms in diameter, about 50 angstroms to about 700 angstroms, about 100 to about 600 angstroms, or about 500 angstroms.
  • the porous solid substrate can form a side or a bottom of a well in a microtiter plate or an equivalent structure.
  • the porous solid substrate comprises a porous bead or a porous microsphere or an equivalent structure; a porous polytetrafluoroethylene filter or a porous filter comprising an equivalent composition; a porous fiber, a porous hollow fiber or a porous fabric or an equivalent structure; a polyacrylamide or an equivalent polymer composition; a polymethacylamide, a methyl methacrylate, a glycidyl methacrylate, a dialkylaminoalkyl-(meth)acrylate, or a N,N-dialkylaminoalkyl (meth)acrylate, or an equivalent composition; an agarose or an equivalent polymer composition; a polyimid or an equivalent polymer composition; a controlled pore silica or porous glass or an equivalent composition; or, a porous foam or an equivalent composition.
  • the porous foam can comprise a poly(D,L glycolic-co-lactic acid) or a poly(D, L-lactide-co-glycolide) (PLGA) or an equivalent composition.
  • the porous solid substrate can also comprise a porous ceramic or an equivalent composition.
  • the porous solid substrate can comprise a poly(ethylene glycol terephthalate) (PEGT) or a polyfbutylene terephthalate) (PBT).
  • the porous solid substrate can comprise a monodispersed carbon nanotube or a nanotube comprising an equivalent composition.
  • the monodispersed carbon nanotube can comprise a patterned porous silicon or an equivalent composition.
  • the porous solid substrate can comprise porous polystyrene or an equivalent composition.
  • the polystyrene can comprise a porous poly(styrene- divinylbenzene) (PS-DVB) or an equivalent composition.
  • PSDB porous poly(styrene- divinylbenzene)
  • the porous solid substrate can comprise a plastic or a plastic co-polymer or an equivalent thereof; a polyvinyl, a polypropylene or a polyester or an equivalent thereof; or, a poly(vinyl alcohol) (PVA) hydrogel nanoparticle.
  • the porous solid substrate comprises a plurality of different nucleic acid (e.g., oligonucleotide) probes, wherein the probes are arranged in spatially defined areas over the surface or the pores or the fibers ofthe association device.
  • nucleic acid e.g., oligonucleotide
  • the pores comprise a closed distal end.
  • the pores can comprise an open distal end, wherein the open distal pore end allows passage of fluid through the pore.
  • substantially only the pore surface comprises an association surface.
  • the distance between the nucleic acid (e.g., oligonucleotide) probe and the charged surface is no more than about 100 angstroms, about 50 angstroms, about 30 angstroms, or about 20 angstroms.
  • the oligonucleotide or the polypeptide probe is at least about 11 to about 20 residues in length.
  • the nucleic acid or polypeptide probes are covalently attached to the association surface.
  • the association surface comprises a streptavidin and the association surface has a net positive (cationic) charge density at a pH lower than pH 5.5 and the association surface has a net negative charge density at a pH higher than pH 5.5.
  • the association surface comprises a histidine or a histidine derivative and the association surface has a net positive (cationic) charge density at a pH lower than about pH 6.7 and the association surface has a net negative charge density at a pH higher than about pH 6.7.
  • the association surface comprises an imidazole or an imidazole derivative and the association surface has a net positive (cationic) charge density at a pH lower than about pH 6.0 and the association surface has a net negative charge density at a pH higher than about pH 6.0.
  • the association surface comprises citrate or citrate derivatives or a carboxylic acid.
  • the association surface comprises an amino acid or peptide linked to the solid substrate surface by its amino terminal end and an animated oligonucleotide linked to the carboxy terminal end ofthe amino acid or peptide.
  • the peptide can comprise [(arg) n -pro] n -arg n , [(arg) n -pro-gly] n -arg n , or [(arg) n - gly-gly] n-argn , wherein n is the integer 2, 3, 4, 5 or 6.
  • the peptide can comprise [(arg) 5 - pro] 5 -arg 5 , [(arg) 5 -pro] 4 -arg 5 , [(arg) 5 -pro-gly] 3 -arg 5 , [(arg) 5 -pro-gly] 4 -arg 5; [(arg) 5 -gly-gly] 3 - arg 5> or [(arg) 5 -gly-gly]4-arg 5 .
  • the contacting conditions comprise a pH higher or lower than the pi ofthe association surface, wherein these conditions are established before contacting the test sample of step (a) with the association device of step (b).
  • a desired pH is established by contacting the device with an aqueous solution buffered to a desired pH.
  • the contacting conditions comprise a pH lower than the pi ofthe association device, sufficient net positive charge density is induced on the association surface to generate a net positive charge density in the pore ofthe device, thereby generating a thermodynamic partitioning equilibrium favorable to the movement of negatively charged molecules into the pore space from the aqueous solution outside ofthe pores and favorable to the movement of positively charged molecules out of the pore space.
  • thermodynamic partitioning equilibrium is favorable to the movement of negatively charged DNA or RNA polynucleotides or negatively charged polypeptides into the pore space from the aqueous solution outside ofthe pores.
  • the contacting conditions comprise a pH higher than the pi ofthe association device
  • sufficient net negative charge density is induced on the association surface to generate a net negative charge density in the pore ofthe device, thereby generating a thermodynamic partitioning equilibrium favorable to the movement of positively charged molecules into the pore space from the aqueous solution outside ofthe pores and favorable to the movement of negatively charged molecules out ofthe pore space.
  • the thermodynamic partitioning equilibrium is favorable to the movement of negatively charged DNA or RNA polynucleotides or negatively charged polypeptides outside ofthe pores.
  • the method further comprises removing a nucleic acid or a polypeptide not associated with a probe by washing with a buffered aqueous solution.
  • the wash conditions can induce or maintain a net positive charge density on the surface of the device if the washing (contacting) step comprises net positive charge density conditions, or, wherein the wash conditions induce or maintain a net negative charge density on the surface ofthe device if the wash (contacting) step comprises net negative charge density conditions.
  • the method can further comprise detecting the nucleic acid or polypeptide remaining associated with the nucleic acid or polypeptide probe after the washing and removal of non-associated sample nucleic acid or polypeptide.
  • the method further comprises removing the nucleic acid or polypeptide by washing under conditions comprising a pH higher than the pi ofthe association surface if the contacting conditions step comprises a pH lower than the pi ofthe association surface, or, by washing in an aqueous solution comprising a pH lower than pi ofthe association surface if the contacting conditions step comprises a pH higher than the pi ofthe association surface.
  • the invention also provides a method for detecting at least a single base pair difference between a nucleic acid in a test sample and an oligonucleotide probe comprising the following steps: (a) providing a test sample comprising a nucleic acid; (b) providing a porous association device ofthe invention; (c) contacting the test sample with the porous association device under conditions that induce the substrate surface or the association surface to have a net positive (cationic) charge density under no salt or low salt conditions; (d) altering the association surface to an anionic environment by changing the conditions to comprise a pH that induces a net negative (anionic) charge density to the association surface, or, a neutral charge density by coating the association surface with a neutral or anionic polymer composition; (e) removing test sample nucleic acid not associated with a probe of the device of step (b) under the altered conditions of step (d); and, (f) detecting nucleic acid remaining hybridized to the nucleic acid probe after step (e).
  • the invention also provides a method for making a hybridization device comprising a nucleic acid (e.g., oligonucleotide) probe linked to a solid substrate comprising the following steps: (a) providing a clean porous polystyrene surface or equivalent; (b) providing a biotinylated oligonucleotide probe; (c) providing a strepavidin tetramer; (d) contacting the biotinylated oligonucleotide probe of step (b) with the strepavidin tetramer of step (c) in an aqueous solution; (e) applying the aqueous solution of step (d) directly to the polystyrene surface of step (a); and, (f) incubating the probe-applied polystyrene of step (e) in a humid environment for a sufficient amount of time to allow stable absorption ofthe strepavidin to the polystyrene surface.
  • the invention also provides a method for making a porous surface of an association device comprising an oligonucleotide or polypeptide probe linked to a solid substrate, wherein the solid substrate comprises a substrate surface comprising an external substrate surface and a plurality of internal pores, wherein the pores comprise a proximal end opening to the external surface to allow passage of fluid into the pores, and wherein the pore surfaces comprise an association surface, comprising: (a) co-polymerizing streptaviden and biotinylated nucleic acid probes into a mixture of acrylamide and bisacrylamide, under conditions wherein a porous matrix polymerizes; or, (b) co-polymerizing streptaviden into a mixture of acrylamide and bisacrylamide, under conditions wherein a porous matrix polymerizes, and, after polymerization, adding biotinylated nucleic acid probe to the polymerized porous matrix by perfusion.
  • the mixture in step (a) or step (b) comprises about 19% acrylamide and about 1% bisacrylamide, or amounts giving equivalent results.
  • the final concentration of streptaviden in the mixture of step (a) or step (b) is about 10 "6 M streptaviden tetramer.
  • the invention also provides a method for making a porous surface of an association device comprising an oligonucleotide or polypeptide probe linked to a solid substrate, wherein the solid substrate comprises a substrate surface comprising an external substrate surface and a plurality of internal pores, wherein the pores comprise a proximal end opening to the external surface to allow passage of fluid into the pores, and wherein the pore surfaces comprise an association surface, comprising the following steps: (a) providing a porous silica matrix; (b) providing a solution of activated silane; (c) contacting the porous silica matrix of step (a) with the activated silane of step (b) by a gas phase or fluid phase deposition.
  • Figure 1 is a diagrammatic representation showing modulation of duplex formation by surface physical chemistry.
  • FIGS 2 A, 2B and 2C are schematic representations of probe coupling methodologies.
  • Figure 3 shows the surface state ionic strength dependence of K-ras 12 mer duplexes.
  • Figures 4A and 4B demonstrate the Ph effects on the electrostatic nature of a prototypical "smart" surface (streptavidin) as revealed by dissociation kinetics of hybridization at pH 7.2 or pH 5.2.
  • Figures 5A and 5B demonstrate the Ph and cation effects on dissociation kinetics.
  • Figure 6 is a schematic of a secondary structure assay.
  • Figures 7A and 7B show hybridization of a hairpin forming target at low ionic strength. Signal intensity given in Relative Light Units (RLUs) from a luminometer.
  • RLUs Relative Light Units
  • Figure 8 is a schematic of duplex formation in a protamine model.
  • Figures 9A and 9B show selectivity enhancement by Salmine Al in Na + solutions (Fig. 9A) versus protamine solutions (Fig. 9B).
  • Figure 10 shows the results of hybridization on the surface with a 19 mer oligonucleotide.
  • Figures 11A and 1 IB are schematic representations of an amino acid hybridization surface showing a plurality of amino acids.
  • Figures 12 to 17 are schematic representations of various hybridization surfaces on solid substrates.
  • Figure 18 illustrates data generated by experiments discussed in Example 13, below.
  • Figure 18 A shows data demonstrating the slow kinetics of a k-ras 1 amplicon hybridization to probes immobilized on a streptavidin surface at high salt and high pH.
  • Figure 18B shows data demonstrating the fast kinetics of k-ras amplicon hybridization to the probes immobilized on a streptavidin surface at low salt and low pH.
  • the invention provides devices and methods for detecting nucleic acids in samples using immobilized probes.
  • the devices and methods ofthe invention provide a nucleic acid association (including, e.g., "hybridization") enhancement effect and high sequence selectivity.
  • the observed association-hybridization enhancement is a general property ofthe interaction between DNA and immobilized probes on the invention's charge-adjustable, or "tunable" device surfaces.
  • the invention is not limited by what molecular, physical or kinetic mechanisms are underlying the observed effects.
  • the data presented here demonstrated that the invention successfully exploits the physical chemistry of device surfaces for the purpose of DNA association-hybridization rate enhancement.
  • very significant enhancement of hybridization rates can be obtained at room temperature, while retaining high selectivity, using the DNA microarray devices of the invention.
  • the applied device surface effects give rise to hybridization under solution state conditions of low salt (e.g., from 0 to about 2 mM) and room temperature (e.g., about 25°C) which are denaturing with respect to undesired secondary structure within target (test sample nucleic acid) strands.
  • the invention provides minimization ofthe effect of target structure as a side reaction to high precision DNA microarray applications.
  • the "tunable surface" association devices (e.g., DNA microarray devices) of the invention can be mass-produced at low cost.
  • Use ofthe methods and devices ofthe invention provides the ability to drive hybridization of test sample nucleic acid to immobilized probe to completion in a few seconds. This very significant increase in rate is of practical significance in the population scale application of DNA microa ⁇ ays, such as, e.g., for use in pharmacogenomics, where hundreds or thousands of samples are to be processed in parallel, or for the use of DNA microarrays in point-of-care applications which would require a very rapid data report on single samples.
  • a charge means the equivalent of one positive (cationic) or one negative (anionic) charge; e.g., the equivalent ofthe amount of charge a strepavidin molecule (or other "tunable" molecule used in the association devices ofthe invention) under conditions comprising a pH lower than the pi of strepavidin has (i.e., a single positive charge), or, when the pi is higher than the pi of strepavidin, the negative charge.
  • a tunable surface of a device ofthe invention comprises at least about 10 11 charges per square millimeter.
  • nucleic acid refers to a deoxyribonucleotide or ribonucleotide in either single- or double-stranded form.
  • the term encompasses nucleic acids, i.e., oligonucleotides, containing known analogues of natural nucleotides which have similar or improved binding properties, for the purposes desired, as the reference nucleic acid.
  • the term also encompasses nucleic-acid-like structures with synthetic backbones.
  • DNA backbone analogues provided by the invention include phosphodiester, phosphorothioate, phosphorodithioate, methylphosphonate, phosphoramidate, alkyl phosphotriester, sulfamate, 3'-thioacetal, methylene(methylimino), 3'-N-carbamate, morpholino carbamate, and peptide nucleic acids (PNAs); see Oligonucleotides and Analogues, a Practical Approach, edited by F. Eckstein, IRL Press at Oxford University Press (1991); Antisense Strategies, Annals ofthe New York Academy of Sciences, Volume 600, Eds. Baserga and Denhardt (NYAS 1992); Milligan (1993) J. Med. Chem.
  • PNAs contain non-ionic backbones, such as N-(2-aminoethyl) glycine units, and can be used as probes (see, e.g., U.S. Patent No. 5,871 ,902).
  • Phosphorothioate linkages are described in WO 97/03211 ; WO 96/39154; Mata (1997) Toxicol. Appl. Pharmacol. 144:189-197.
  • nucleic acid is used interchangeably with the terms gene, cDNA, mRNA, oligonucleotide primer, probe and amplification product.
  • oligonucleotide probe as used herein defines a molecule comprised of more than three deoxyribonucleotides or ribonucleotides. The exact length will depend on many factors leading to the ultimate function or use ofthe oligonucleotide probe, including temperature, source ofthe probe and use ofthe method.
  • the oligonucleotide probe can occur naturally as in a purified restriction digest or be produced synthetically.
  • the oligonucleotide probe is capable of binding to any nucleic acid (e.g., DNA or RNA) target when placed under conditions which induce binding ofthe target to the oligonucleotide probe.
  • the oligonucleotide probes can be at least greater than about 10 mer in length, about 20-mer in length, or can range from about 10 to 30 to 50 mer, or greater. Sensitivity and specificity ofthe oligonucleotide probes are determined by the probe length, uniqueness of sequence and localized environment.
  • Probes which are too short, for example less than 10 mer, may show non-specific binding to a wide variety of sequences in the DNA or RNA.
  • the probes ofthe invention can be linear or circular or stem-loop.
  • single-stranded circular oligonucleotides can bind to both single-stranded and double-
  • probes which are substantially complementary to a strand of DNA or RNA will bind to that specific strand of DNA and RNA.
  • the probe sequence need not reflect the exact complementary sequence ofthe DNA or
  • base mismatch refers to a change in the oligonucleotide such that when the probe lines up with the known sequence an abnormal bonding pair of nucleotides is formed.
  • G guanine
  • C cytosine
  • T thymine
  • a variety of base mismatches can occur, for example G-G, C-C, A-A, T-T, A-G, A-C, T-G or T-C.
  • This mispairing and the effects of localized environments on the efficiency of binding is used in the present invention to detect the mispairing.
  • the probe When there are base mismatches between a probe and DNA or RNA, the probe will bind preferentially to the strand that has the fewest base mismatches under the most stringent conditions.
  • the method ofthe present invention provides a way to alter the conditions such that the combination with the fewest base mismatches will preferentially bind to the probe.
  • a "solid substrate” or “substrate surface” is the material which forms the solid support for the device or the association (e.g., hybridization) reaction. It is composed of a substrate surface and an association (e.g., hybridization) surface.
  • the substrate surface can be selected from a variety of materials including, e.g., polyvinyl, polystyrene, polypropylene, polyester, other plastics, glass, Si0 2 , other silanes, gold or platinum, see further examples described, below.
  • the solid surfaces can be derivatized, e.g., thiol-derivatized biopolymers (including nucleic acid or oligonucleotide probes) and organic thiols can be bound to a metal solid substrate; see, e.g., U.S. Patent No. 5,942,397 (see below for more examples).
  • association surface comprises a composition that binds to the solid surface, either covalently or non-covalently.
  • the oligonucleotide probe is immobilized to the device by binding (covalently or non- covalently) to the attached composition.
  • the device ofthe invention promotes the association of nucleic acid in a sample applied to the device to the immobilized oligonucleotide. This can include, e.g., increased kinetics of association or disassociation (which, in some embodiments, can depend on whether the conditions of association comprise a net cationic charge or a net anionic charge, respectively).
  • association includes, e.g., hybridization (e.g., Watson-Crick base pairing), Hoogsteen-based double or triple helix formation, reverse Hoogsteen hydrogen bonding interactions, and the like. See, e.g., Giovannangeli (1997) Antisense Nucleic Acid Drug Dev. 7:413-421; U.S. Patent Nos. 5,473,060; 6,004,750.
  • Hoogsteen triple-helical three- way junctions can be designed from the same sequences used for the Watson-Crick triple-helical three-way junctions, see, e.g., Husler (1994) Arch. Biochem.
  • the invention can comprise oligonucleotides (also called foldback triplex-forming oligonucleotides) that can hybridize to single-stranded complementary polypurine nucleic acid targets by Hoogsteen base pairing as well as by Watson-Crick base pairing (see, e.g., Kandimalla ( 1995) Nucleic Acids Res. 23 : 1068-74).
  • oligonucleotides also called foldback triplex-forming oligonucleotides
  • Nucleic acid analogs can also be used to design the oligonucleotide probes ofthe invention, e.g., peptide nucleic acids (PNAs) and analogues of peptide nucleic acids can be designed to form duplex, triplex, and other structures with nucleic acids, see, e.g., U.S. Patent No. 5,986,053.
  • PNAs peptide nucleic acids
  • analogues of peptide nucleic acids can be designed to form duplex, triplex, and other structures with nucleic acids, see, e.g., U.S. Patent No. 5,986,053.
  • the invention can also be used to isolate or detect double stranded nucleic acids without the need for denaturing before application to the device; e.g., double-stranded DNA complexes to the immobilized oligonucleotide probe to generate a triple helix.
  • the DNA ofthe sample can then be washed off, or recovered intact, by treating (washing) with a reagent that breaks the bonds between the oligonucleotide and the intact double stranded DNA while not affecting the Watson-Crick base pairs ofthe double helix. See, e.g., U.S. Patent No. 5,482,836.
  • the test sample nucleic acid not specifically associated with the immobilized probe is removed.
  • sample nucleic acid not “specifically associated” with probe can be washed off under conditions equivalent to those used in as wash conditions in the methods ofthe invention, e.g., wherein the surface ofthe device has a neutral or negative net charge density and the wash conditions comprise low salt conditions (see definition below).
  • immobilized as with “immobilized nucleic acid probe” means that the oligonucleotide probe can be attached to a surface (e.g., the solid support surface or an association surface ofthe device ofthe invention) in any manner by and methods; including, e.g., reversible or non-reversible binding, covalent or non-covalent attachment, and the like.
  • low salt conditions includes any set of conditions wherein the sodium or equivalent cation concentration is below that of physiologic conditions; for example, in various embodiments, low salt conditions comprise about 100 mM, about 75 mM, about 50 mM, about 25 mM, about 20 mM, about 15 mM, or about 5 mM, or about 2 mM, or less than 2 mM sodium or equivalent cation (such conditions include, e.g., sodium phosphate, sodium chloride, and the like).
  • streptavidin as used herein includes all derivatives and analogs that are functional equivalents, particularly the ability to bind biotin or equivalents thereof and have a pi within an upper an lower range compatible to use ofthe "tunable" surface ofthe invention, as described herein, e.g., as neutraviden (although streptavidin has a pi of 5.5, streptavidin derivatives and analogs are not limited to such a pi). Streptavidin derivatives and analogs are well known in the art and are described, e.g., in 5,973,124; 5,846,537; 5,672,691; 5,489,528; 5,328,985; 5,272,254; Stayton (1999) Biomol. Eng.
  • This invention provides devices and methods for use in the detection and/or isolation of nucleic acids.
  • the devices and methods ofthe invention use immobilized oligonucleotide probes. These probes can be made and expressed in vitro or in vivo, any means of making and expressing nucleic acids and probes used in the devices or practiced with the methods ofthe invention can be used.
  • the invention can be practiced in conjunction with any method or protocol known in the art, which are well described in the scientific and patent literature.
  • nucleic acid sequences ofthe invention e.g., probes ofthe devices, whether, e.g., RNA, cDNA, fragments of genomic DNA, can be isolated from a variety of sources, genetically engineered, amplified, and/or expressed recombinantly. Any recombinant expression system can be used, including, in addition to mammalian cells, e.g., bacterial, yeast, insect or plant systems.
  • nucleic acids can be synthesized in vitro by well-known chemical synthesis techniques, as described in, e.g., Carruthers (1982) Cold Spring Harbor
  • Double stranded DNA fragments may then be obtained either by synthesizing the complementary strand and annealing the strands together under appropriate conditions, or by adding the complementary strand using DNA polymerase with an appropriate primer sequence.
  • nucleic acids such as, e.g., generating mutations in sequences, subcloning, labeling probes, sequencing, hybridization and the like are well described in the scientific and patent literature, see, e.g., Sambrook, ed., MOLECULAR CLONING: A LABORATORY MANUAL (2ND ED.), Vols. 1-3, Cold Spring Harbor Laboratory, (1989); CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, Ausubel, ed.
  • Nucleic acids can be analyzed and quantified by any of a number of general means well known to those of skill in the art. These include, e.g., analytical biochemical methods such as NMR, spectrophotometry, radiography, electrophoresis, capillary electrophoresis, high performance liquid chromatography (HPLC), thin layer chromatography (TLC), and hyperdiffusion chromatography, various immunological methods, e.g.
  • Oligonucleotide primers can be used to generated device probes or to amplify an "associated" or hybridized nucleic acid for detection or replication purposes. These techniques can also be used for site-directed mutagenesis (e.g., to generate alternative probes). Amplification methods are also well known in the art, and include, e.g., polymerase chain reaction, PCR (PCR PROTOCOLS, A GUIDE TO METHODS AND APPLICATIONS, ed. Innis, Academic Press, N.Y. (1990) and PCR STRATEGIES (1995), ed.
  • LCR ligase chain reaction
  • transcription amplification see, e.g., Kwoh (1989) Proc. Natl. Acad. Sci. USA 86:1173
  • self-sustained sequence replication see, e.g., Guatelli (1990) Proc. Natl. Acad. Sci. USA 87:1874)
  • Q Beta replicase amplification see, e.g., Smith (1997) J. Clin. Microbiol. 35:1477-1491
  • automated Q-beta replicase amplification assay see, e.g., Burg (1996) Mol.
  • RNA polymerase mediated techniques e.g., NASBA, Cangene, Mississauga, Ontario
  • Association / Hybridization Devices e.g., NASBA, Cangene, Mississauga, Ontario
  • the solid support surface comprises an "association" surface, which, e.g., can be a “hybridization” surface.
  • the association/ hybridization surface can be selected from a variety of materials, e.g., including those shown in Table 1 (Example 11) and other materials such as organic acids, inorganic acids, organic bases and inorganic bases. This can include amino acids, peptides, oligopeptide, polypeptides, peptidomimetics, other short polymers or organic molecules. When amino acids are used, alternative embodiment can use methyl esters because of commercial availability and the fact that they are not altered by the formation reactions (binding ofthe association surface to the support surface).
  • “Peptidomimetics” include synthetic chemical compounds that have substantially the same structural and/or functional characteristics ofthe co ⁇ esponding composition, e.g., the peptides, oligopeptides (e.g., oligo-histidine, oligo-aspartate, oligo- glutamate, poly-(his) 2 (gly) ⁇ , and poly-(his) 2 (asp) ⁇ ), polypeptides, imidazole derivatives or equivalents used in the association surface ofthe invention.
  • the mimetic can be either entirely composed of synthetic, non-natural analogues of amino acids, or, is a chimeric molecule of partly natural peptide amino acids and partly non-natural analogs of amino acids.
  • the mimetic can also incorporate any amount of natural amino acid conservative substitutions as long as such substitutions also do not substantially alter the mimetic's structure and/or activity.
  • peptide bonds can be joined by peptide bonds, other chemical bonds or coupling means, such as, e.g., glutaraldehyde, N-hydroxysuccinimide esters, bifunctional maleimides, N,N'-dicyclohexylcarbodiimide (DCC) or N,N'-diisopropyl-carbodiimide (DIC).
  • DCC N,N'-dicyclohexylcarbodiimide
  • DIC N,N'-diisopropyl-carbodiimide
  • association surface can also be an "effective association surface” (e.g., "effective hybridization surface”).
  • an oligonucleotide probe e.g., modified probes
  • an oligonucleotide probe can have a sufficient charge that when linked to the solid substrate, it creates a localized positive, neutral or negative environment at the surface ofthe solid substrate. This localized environment contributes to creation ofthe hybridization surface.
  • the support surface (comprising an "association” surface or an “effective association surface”) can provide positive, neutral or negative charge density environments used to practice the present invention.
  • the device ofthe invention can provide different charge density conditions; and, in alternative embodiments, the charge density conditions ofthe surface ofthe device can be changed (i.e., the device is "tunable" to different electrostatic/ charge densities, including cationic, neutral or anionic conditions). Not all of the device need be the same charge density; for example if an exemplary device comprises a plurality of wells to provide a plurality of association/ hybridization microenvironments, each well can have a different charge density.
  • alternative devices ofthe invention can have a plurality of different solid support surfaces, association surfaces, or both.
  • the association / hybridization surface can be composed of a single compound or be composed of a combination of (e.g., combinatorial association) or a plurality of different compounds.
  • a desired set of conditions e.g., a given oligonucleotide probe (e.g., its length, source, G/C content), how the probe has been modified (e.g., conjugated to biotin), for the probe to bind to the association / hybridization surface, for, e.g., distinguishing specific DNA or RNA target sites, specific Watson-Crick base pairing or Hoogstein base associations, isolating nucleic acid from sample, and the like.
  • association / hybridization performed on a surface can include the association / hybridization surface itself as an integral part ofthe binding reaction. This is illustrated in Figure 1.
  • An important aspect of this illustration is the availability of free reactive groups on the surface. These free reactive groups can be secondarily modified after the probe linkage to the association / hybridization surface. This secondary modification can be performed with an extremely large repertoire of monomeric or oligomeric molecules using the same straightforward coupling chemistry used to link the probes. Examples of such molecules include all primary and modified amino acids, oligopeptides, polysaccharides, lipids and at least tens of thousands of other small organic molecules.
  • the association / hybridization surface can include either only one of these molecules on the surface or some combination of these molecules. Thus, at least one molecule is used to alter the surface charge and water molecule binding (wetting) ofthe association / hybridization surface.
  • association/ hybridization device which exploits surface physical chemistry to enhance the selectivity and sensitivity of association/ hybridization assays for detecting DNA or RNA sequences.
  • This association/ hybridization device comprises a solid substrate and an oligonucleotide probe, wherein the solid substrate includes an association/ hybridization surface having a neutral or negative charge density, said association/ hybridization surface accessible for linking to the oligonucleotide probe by a covalent linkage or a slowly reversible, non-covalent linkage.
  • the oligonucleotide probes ofthe device ofthe invention are linked to the association/ hybridization surface at a distance within which the charge density ofthe association surface (or effective association surface) or solid support surface can measurably influence the specificity or kinetics of probe-nucleic acid (of test sample) association and/or dissociation; typically, this is no more than about 100 angstroms. However, one skilled in the art will recognize that this distance is not an exact measurement.
  • the magnitude ofthe surface effect decreases progressively as the distance ofthe association event from the net surface charge increases.
  • the distance When the distance is about 100 angstroms, the net charge "surface effect" usually begins to become negligible relative to the bulk solution effect; however, under some circumstances the distance can be greater than 100 angstroms and remain significant.
  • the distance (between net electrostatic charge density ofthe device and the nucleic acid to interact with the immobilized probe) is selected to allow for the desired amount of physical or electrostatic interaction between the target nucleic acid (e.g., DNA or RNA) and the support surface or hybridization surface.
  • the distance effects the binding equilibrium.
  • the physical or electrostatic interaction can include, e.g., an interaction between the duplex and (i) surface electric field, or (ii) the local high cation concentration near the surface.
  • the probe is linked at a distance of no more than about 75 angstroms, about 50 angstroms, about 40 angstroms, or about 30 angstroms from the association/ hybridization surface, or, the linkage is about 20 angstroms.
  • the support surface can be made negatively charged by layering a thin negatively charged protein film on the solid substrate.
  • the invention provides associate/ hybridization devices comprising an oligonucleotide probe linked to a solid substrate.
  • the surface can be of a rigid, semi-rigid or flexible material.
  • the surface can be flat or planar, be shaped as wells, raised regions, etched trenches, pores, beads, filaments, or the like.
  • Solid substrates can be of any material upon which an oligonucleotide can be directly or indirectly bound, or any surface upon which an association surface can be directly or indirectly bound.
  • suitable materials can include paper, glass (see, e.g., U.S. Patent No. 5,843,767), ceramics, quartz or other crystalline substrates (e.g.
  • gallium arsenide metals, metalloids, polacryloylmorpholide, various plastics and plastic copolymers, NylonTM, TeflonTM, polyethylene, polypropylene, poly(4-methylbutene), polystyrene, polystyrene/latex, polymethacrylate, poly(ethylene terephthalate), rayon, nylon, poly( vinyl butyrate), polyvinylidene difluoride (PVDF) (see, e.g., U.S. Patent No. 6,024,872), silicones (see, e.g., U.S. Patent No. 6,096,817), polyformaldehyde (see, e.g., U.S. Patent Nos.
  • PVDF polyvinylidene difluoride
  • cellulose see, e.g., U.S. Patent No. 5,068,269, cellulose acetate (see, e.g., U.S. Patent No. 6,048,457), nitrocellulose, various membranes and gels (e.g., silica aerogels, see, e.g., U.S. Patent No. 5,795,557), paramagnetic or superparamagnetic microparticles (see, e.g., U.S. Patent No. 5,939,261) and the like.
  • the surface can be derivatized for application ofthe association surface or other compounds.
  • Reactive functional groups can be, e.g., hydroxyl, carboxyl, amino groups or the like.
  • Silane e.g., mono- and dihydroxyalkylsilanes, aminoalkyltrialkoxysilanes, 3-aminopropyltriethoxysilane, 3 -aminopropyltrimethoxy silane
  • Silane can provide a hydroxyl functional group for reaction with an amine functional group.
  • the solid substrate is polystyrene
  • the association/ hybridization surface is streptavidin
  • the oligonucleotide probe has been modified to include biotin and the modified probe is linked to the association/ hybridization surface by a non-covalent interaction ofthe biotin with the streptavidin.
  • the solid substrate is polyvinyl, polystyrene, polypropylene or polyester
  • the association/ hybridization surface is a thin carboxylic acid surface placed on the solid substrate and the oligonucleotide probe has been modified to include an amine group and the modified probe is covalently linked to the association/ hybridization surface.
  • the oligonucleotide probe is linked to a glass solid substrate by an epoxysilane linkage to a terminal amine modification.
  • This linked solid substrate/probe creates an effective association/ hybridization surface because the probe is sufficiently negative to provide a negatively charged environment in the probe/solid substrate localized area.
  • the association/ hybridization surface has a composition which switches electrostatic charge in the range of pH 5 to 8.
  • the association/ hybridization device has a association/ hybridization surface where the electrostatic field is maintained at a negative potential. This allows for field-induced destabilization of mismatched binding.
  • association/ hybridization surface has a composition where the surface electrostatic field is more cationic during association/ hybridization and serves as a nucleic acid attractor, but becomes more anionic during washing so as to create a field-induced destabilization of association or mismatch binding during washing.
  • One embodiment ofthe present invention is the use of film chemistries to produce an association/ hybridization surface which has switchable ("tunable") electrostatics.
  • the surface is cationic or neutral at a pH of about 5 to 6 so as to attract nucleic acid targets to the surface during hybridization, but which become negatively charged at a pH of about 7 to 8 to confer a selective electrostatic interaction between target molecules and the surface during washing.
  • the net electrostatic charge density of a device ofthe invention is dependent on the pi ofthe composition (or net pi, if more than one composition) comprising the association surface and/or solid support surface.
  • the composition ofthe association/ hybridization surface is selected from the group consisting of streptavidin, imidazole derivatives, carboxylic acids and other groups with pK values near neutrality. This can include histidine derivatives and citrate. It should also be noted that although an individual carboxylic acid or imidazole may not have a pK near neutrality the pK may be effectively, near neutral when various combinations of compounds are used.
  • the association / hybridization surface can comprise arginine or arginine derivatives. Further, the skilled artisan will recognize that the association/ hybridization surface can include, e.g., amino acids, amino acid esters or a mixture of thereof.
  • a specific embodiment includes a association/ hybridization surface comprised of a Salmine Al -probe chimera linked to the support surface.
  • Another specific embodiment includes a association/ hybridization surface comprising a Salmine Al and or Salmine A 1 -probe chimera. This association/ hybridization surface is selected to create highly selective association/ binding of target to the surface in the absence of exogenous salt ions.
  • Porous foams of macroporous hydrogels are described, e.g., in Courtney (1999) J. Biomater. Sci. Polym. Ed. 10:1063-1077.
  • Low density open cell organic foams are described, e.g., in U.S. Patent No. 5,945,084.
  • Amorphous poly(D,L) glycolic-co-lactic acids are described, e.g., in Ranucci (1999) Tissue Eng. 5:407-420.
  • Porous ceramics are described, e.g., in Ohgushi (1999) J. Biomed. Mater. Res.
  • porous membranes are described, e.g., in U.S. Patent Nos. 6,077,800; 5,269,926.
  • Porous sol-gels are described, e.g., in Juszczak (1999) J. Biol. Chem 274:30357-30360.
  • Porous polytetrafluoroethylene filters are described, e.g., in Holmquist (1999) J. Biochem. Biophys. Methods 41:49-60.
  • Porous matrices of poly(ethylene glycol terephthalate) (PEGT) and poly(butylene terephthalate) (PBT) are described, e.g., in van Dorp (1999) J. Biomed.
  • a hydrophilic porous membrane of a non-crystalline hydrophobic polymer and an in situ crosslinked hydrophilic acrylate polymer is described, e.g., in, U.S. Patent No. 6,083,393.
  • Surface-grafted microporous membranes are described, e.g., in U.S. Patent No. 5,547,575.
  • Microporous polyvinylidene fluoride membranes are described, e.g., in U.S. Patent No. 5,531 ,900.
  • Porous membranes comprising cellulose compounds are described, e.g., in U.S. Patent No. 5,980,746.
  • a microporous membrane comprising a partially fluorinated polyolefin membrane is described, e.g., in, U.S. Patent No. 5,209,849.
  • a microfabricated thin-film membrane filter is described, e.g., in, U.S. Patent No. 5,985,328.
  • Various forms of porous beads, membrane, particles, nanotubes and microchannel devices and the like, are also described in, e.g., U.S. Patent Nos.
  • a porous solid substrate is made by polymerization of acrylamide-bisacrylamide.
  • Tunable elements e.g., streptavidin, histidine, imidazole, peptides, citrate or citrate derivatives or a carboxylic acid, and the like, as described herein
  • the method comprises co-polymerizing streptaviden into a mixture of about 19% acrylamide and about 1% bisacrylamide.
  • Covalent linkage can be obtained by linkage ofthe amino terminus ofthe peptide or the lysine side chains of streptaviden to a carboxylate or succimidate or by an NHS ester moiety, which can introduced into the porous polymer matrix.
  • the method involves the use of a porous silica matrix.
  • Tunable elements can be linked by coating the pores ofthe matrix with a monolayer of an activated silane (such as an epoxysilane) via gas phase or fluid phase deposition.
  • the tunable elements are introduced by covalent linkage to the silane layer as through covalent coupling to the terminal amine group of a peptide, or by covalent attachment of streptaviden or a streptaviden derivative, such as neutraviden.
  • the method comprises co- polymerization of streptaviden into an about 19% acrylamide, 1% bisacrylamide matrix at the time of polymerization.
  • the concentration of streptaviden tetramer can vary, depending on conditions and desired outcome; for example, it can range from about 10 "5 M to about 10 "7 M, or, it can be about 10 "6 M.
  • Biotinylated nucleic acid probes can also be added either to the polymerization mixture, or after polymerization ofthe acrylamide-streptaviden porous matrix, by perfusion, or equivalent methods.
  • concentration of biotinylated nucleic acid probes can vary depending on conditions and desired result; for example, the concentration can range from about lO ⁇ M to about 10 "7 M, or, about lxlO "6 M to about 5xlO "6 M, or equivalents.
  • the substrate surface comprising an external substrate surface and a plurality of internal pores is made by contacting the porous silica matrix with an activated silane, or equivalent, by a gas phase or fluid phase deposition.
  • a source of porous silica matrix can be, e.g., controlled pore glass (CPG) (CPG, Inc., Lincoln Park, NJ).
  • the activated silane can be in an about 10 to 50% v/v in organic solvent, such as methanol or xylene or equivalent.
  • the gas (vapor) phase deposition method comprises mixing activated silane to about 1 : 1 to 1 :4 in xylene contained in small, partially open vessel (such as glass petri dish) in a vacuum oven.
  • Substrate material to be derivatized is placed in the oven and silane is vapor deposited under vacuum and elevated temperature (typically 80° C) for about 8 to about 48 hours.
  • the fluid phase deposition method comprises preparing activated silane as a 10% solution (v/v) in methanol.
  • Substrate material to be derivatized is immersed in this solution for about 10 to about 30 min. After silanization, substrate is rinsed thoroughly with pure methanol and subsequently cured at about 100° C in an oven.
  • the Modified nylon membranes may be obtained containing amine and carboxylate groups for covalent coupling of proteins, peptides, and
  • a "tunable" porous surface can then be made using the abovementioned strategies
  • Controlled pore glass as mentioned above, is available with a variety of surface coatings including aminosilane, biotin, streptavidin, and many more. These functional groups may then be employed to incorporate the abovementioned "tunable" strategies
  • Another embodiment includes a method for detecting single base difference in a target area of a strand of DNA or RNA, comprising, mixing any ofthe association/ hybridization devices ofthe present invention with DNA or RNA containing the target area to be detected, allowing sufficient time for the probe on the association/ hybridization device to associate/ hybridize to the target area ofthe DNA or RNA, altering the environment ofthe associated/ hybridized probe/DNA or RNA, and detecting the probe/DNA or RNA remaining after the alteration.
  • a variety of methods are available for altering the environment, one common method is to wash the bound probe/DNA or RNA with a solution having the specific characteristics to induce the change.
  • pH changes e.g., a pH above the pi ofthe composition (or net pi if more than one composition) comprising the association surface to create a net negatively charged surface on the device
  • ionic changes e.g., below physiologic conditions, e.g., 2 to 20 mM sodium phosphate
  • other conditions e.g., temperature changes, or, hybridization stabilizing or destabilizing compositions in the wash solution.
  • Another embodiment is a method and device to obtain a precise balance of surface charge and or charge switching ("tuning") during association/ hybridization and washing; and/or surface water binding by using parallel combinatorial screenings of compounds for hybridization surfaces.
  • this includes the use of amino acid derivatives as association/ hybridization surfaces.
  • the rate (kinetics) and specificity of specific associations is affected by the surface itself (i.e., the localized environment). This effect may be exploited to accentuate the thermodynamic consequences of subtle, single base target-probe mismatches in a variety of underlying substrate materials.
  • the present invention provides the ability to modulate this surface effect to enhance duplex formation.
  • thermodynamic stability of probe- target duplexes This includes the altered reactivity of complementary nucleic acids at or near a solid-liquid interphase transition. In some circumstances, only by taking into account the above mentioned boundary conditions will perfectly matched duplexes be feasibly distinguished from relatively stable yet mismatched target-probe pairings.
  • the present invention is a rational use of solid support materials and the chemical alterations of such materials such that the surface becomes an active participant in the association/ hybridization process in a predictable and beneficial manner.
  • This invention encompasses the following:
  • duplex formation at the surface differs significantly from that in bulk solution and is selectively destabilizing for mismatched duplexes at low cation concentrations.
  • the chemical nature ofthe surface may be modified quite readily to provide surfaces differing in the nature of their electrostatic charge, hydrophobicity, density of probe molecules per unit area, tether length, and other characteristics. Further, the surfaces may be chemically modified such that the physical manifestations are "tunable" by altering bulk solution parameters (e.g., pH, temperature, and bulk cation concentration, or inclusion of other compositions).
  • bulk solution parameters e.g., pH, temperature, and bulk cation concentration, or inclusion of other compositions.
  • One ofthe advantages ofthe present invention is that there is a device and a method which can be used for association hybridization of probes to target DNA or RNA at low bulk ion concentrations.
  • This method is effective because the surface loading of cations on a solid support creates a hybridization surface that results in a high local cation density near the surface.
  • This localized high cation density can be used to obviate target folding and side reactions.
  • the present invention contemplates a device in which the support surface and hybridization surfaces interact to form a high local cation density for facilitating the binding of a probe to a target nucleic acid (e.g., DNA, RNA) sequence.
  • a target nucleic acid e.g., DNA, RNA
  • One specific advantage ofthe present invention is that the electrostatic field created on the surface of a solid substrate by the association/ hybridization surface can be used to enhance the selectivity of duplex binding due to the interaction between the mismatches in the target, the probe and the electrostatic field of the surface.
  • a surface field is created which is switchable, or "tunable.”
  • This ability to switch the surface charge allows for a surface with a local ion electrostatic field which attracts the nucleic acid (e.g. , DNA or RNA) during the association/ hybridization stage yet can be altered such that local ion electrostatic field changes during the washing phase to a net negative charge density (to "repel” negatively charged nucleic acid).
  • the probe cannot selectively interact with nucleic acid with base pair mismatches (cannot provide preferential binding).
  • the charge "switching” also promotes disassociation among the mismatched target sequences. In this procedure, the target sequence which has the fewest mismatches with the probe will preferentially bind to the probe.
  • Another advantage ofthe present invention is that salmine Al and its derivatives either used alone or as part of a covalent probe complex will obviate the requirement for exogenous cations in an association/ hybridization assay.
  • Another crucial aspect ofthe present invention is that by the use of combinatorial methods the device or the methods ofthe present invention can be fine-tuned.
  • the surface ofthe device ofthe invention can become a cationic attractor during association/ hybridization and a negatively charged discriminator during washing.
  • the method employs a combinatorial surface chemistry using amino acid derivatives as the surface chemistry.
  • a combinatorial surface chemistry which generates a plurality of compounds for the association/ hybridization surface is especially "attractive" (i.e., having a net cationic charge density) when using amino acid derivatives (e.g., the pi of primary amines is 10).
  • aminated polystyrene is coated as a thin layer of succinic acid on a solid surface substrate of a device ofthe invention.
  • succinic anhydride By reaction with succinic anhydride a probe will be linked to this surface by amide bond formation between an amine modified probe and the carboxylated surface.
  • Remaining (unused) carboxylates can be modified with the methyl ester of amino acids employing the same carboxylic acid coupling used to attach the probe.
  • modified amino acids are added in pairs so to create surfaces with all possible mole ratios of surface chemistries (i.e., carbohydrate, amino acid 1, amino acid 2, etc.). Because of their commercial availability, the O-methyl esters ofthe amino acids were chosen as an example to demonstrate this principle.
  • the standard amino acids can be varied to obtain the desired surface physical chemistries.
  • Various amino acids and their characteristics e.g., pis
  • association/ hybridization devices can be developed, made and used.
  • An additional embodiment includes a method of making a library of association/ hybridization devices.
  • One method to generate the library of association/ hybridization devices involves using association/ hybridization devices each having a substrate surface of glass and an oligonucleotide probe linked to the substrate surface by an epoxysilane linkage to a terminal amino modification to form a substrate surface-probe complex wherein said complex forms an effective association/ hybridization surface.
  • the method comprises the step of converting unreacted epoxysilane groups to the co ⁇ esponding cationic, neutral or anionic derivative by treating said epoxysilane groups with a reaction compound selected from the group consisting of, an amino acid, an amino acid ester and mixture thereof.
  • Another method to generate a library of association/ hybridization devices involves using association/ hybridization devices each having a substrate surface of glass and an oligonucleotide probe linked to the substrate surface by an epoxysilane linkage to a terminal amino modification to form a substrate surface-probe complex wherein said complex forms an effective association/ hybridization surface.
  • the unreacted epoxysilane groups are converted to the co ⁇ esponding cationic, neutral or anionic derivative by treating said epoxysilane groups with a reaction compound consisting of an amino containing chemical compound.
  • a further method to generate a library of association/ hybridization devices includes using association/ hybridization devices each having a substrate surface selected from the group consisting of polyvinyl, polystyrene, polypropylene and polyester, a hybridization surface of carboxylic acid placed on the support surface, an oligonucleotide probe modified to include a compound selected from the group consisting of an amino acid, an amino acid ester and mixture thereof.
  • the modified oligonucleotide probe is reacted with the carboxylic acid group to covalently link the probe to the association/ hybridization surface.
  • a library of association/ hybridization devices with multiple association/ hybridization surfaces is generated in a glass bottom microtiter plate by treating each well separately with a reaction compound.
  • each well can provide a different association/ hybridization surface if it is treated with a different reaction compound or mixture of reaction compounds.
  • An additional embodiment includes a method to screen the activity of a library of association/ hybridization devices, comprising the steps of mixing the library with nucleic acid (e.g., DNA or RNA) containing a target area to be detected; allowing sufficient time for the target area to associate/ hybridize to the library of association/ hybridization devices; removing the non-associated or non-hybridized nucleic acids (e.g., DNA or RNA); and detecting the nucleic acid (DNA or RNA) hybridized to the association/ hybridization surface.
  • nucleic acid e.g., DNA or RNA
  • Another embodiment includes a library of association/ hybridization devices comprising a plurality of oligonucleotide probes; and a plurality of solid substrate, wherein each solid substrate has a support surface with a neutral or negative electrostatic field and a association/ hybridization surface wherein each association/ hybridization surface is accessible for linking one ofthe plurality of oligonucleotide probes to said solid substrate and wherein said oligonucleotide probe is linked to the association/ hybridization surface ofthe solid substrate at a distance of no more than about 100 angstroms.
  • One prefe ⁇ ed embodiment of the library includes a microtiter plate where each well in the plate is a different association/ hybridization device (e.g., has a different "association surface" but the same solid support surface).
  • the invention's charge-adjustable, or “tunable” device surfaces and methods ofthe invention can be adapted to any a ⁇ ay-based hybridization detection devices, also called “genosensors,” or (miniaturized) “DNA chips,” or “biochips” and the like.
  • a ⁇ ay-based hybridization detection devices also called “genosensors,” or (miniaturized) "DNA chips,” or “biochips” and the like.
  • Such devices and their applications are well known in the art, including, e.g., as described in U.S. Patent Nos.
  • the device can also comprise other ancillary functions, such as, e.g., tubes or channels which allow for the transportation and flow ofthe test sample in solution, reagents, wash and hybridization buffers, and the like (see, e.g., U.S. Patent Nos. 6,010,608; 5,843,767); for sample manipulation, e.g., mixing, pumping, fluid direction (i.e., valves) and the like; detection of compositions (e.g., fluorimetry, mass spectrometry (see, e.g., U.S. Patent No. 5,547,835), photospectrometry, detecting charged or radioactive labels, and the like, see, e.g., U.S. Patent Nos.
  • ancillary functions such as, e.g., tubes or channels which allow for the transportation and flow ofthe test sample in solution, reagents, wash and hybridization buffers, and the like (see, e.g., U.S. Patent Nos. 6,
  • Fluorescent probes can be detected with a variety of imaging systems known in the art (see, e.g., U.S. Patent No. 5,631 ,734).
  • imaging systems known in the art (see, e.g., U.S. Patent No. 5,631 ,734).
  • a light source e.g., lamp or laser
  • a camera and imaging optics can also be used.
  • a computer can also be used to transform this data (e.g., fluorescent intensity) into various formats, calculating kinetics and binding affinities, and the like.
  • kits comprising the "tunable surface” devices ofthe invention.
  • the kits further comprise reagents for practicing the methods of the invention.
  • reagents include buffers; including, e.g., hybridization buffers comprising pH sufficiently acidic to induce a cationic (positive) surface charge density in the device surface; and, a wash buffer sufficiently basic to induce an anionic (negative) surface charge density.
  • the hybridization buffer can also be a low salt or no salt buffer; and, the wash buffer can comprise physiologic levels of sodium ions, or equivalents.
  • the kits can further comprise printed matter, e.g., written instructions for using the devices and practicing the methods ofthe invention.
  • Figure 2 illustrates covalent and non-covalent probe immobilization methodologies which were employed for surface hybridization modeling studies.
  • Figure 2A demonstrates the use of streptavidin coated microtiter plate wells. In this procedure a streptavidin monolayer hybridization surface was produced by an aqueous deposition of a dilute solution ofthe protein to the polystyrene wells. Probes were modified by attaching biotin to the probes. The modified probes were then attached to the hybridization surface by the non-covalent biotin-streptavidin interaction.
  • Figure 2B demonstrates the use of aminated plastic surfaces.
  • the polystyrene was aminated by gas-phase plasma animation.
  • Surface amines were converted to the carboxylic acid by reaction with succinic anhydride.
  • Amine-modified probes were linked to the surface by amide formation, mediated by EDC and HSSI.
  • Figure 2C demonstrates the use of epoxysilanized Si0 2 surfaces. In this procedure an epoxysilane monolayer was affixed to Si0 2 by vapor deposition. The probe was linked to the monolayer by secondary amine formation to amine-modified probe.
  • Figure 3 represents several possible matched and mismatched probe-target pairings from the K-ras oncogene codons 12 and 13. From Figure 3 it is readily apparent that: 1. The cation dependence of duplex formation is very shallow over the higher Na + concentration range (approximately 1 M to 100 mM) and then begins to lower the K a values for binding in a manner consistent with the severity ofthe mismatch in the range between 100 and 10 mM Na + . 2. The rank order of mismatched base pairings is consistent with known thermodynamic stabilities (i.e., Perfect match > G_A type mismatch > other non-G type single base mismatches > double base mismatches).
  • the surface itself being inherently negatively charged or becoming so after the coupling of negatively charged probe molecules, coordinates Na + ions such that the effective molar concentration of cations near the surface is much greater than that in bulk solution. This phenomenon was previously unknown for nucleic acid surface hybridization.
  • Example 3 Field Effects manifest Near a "Tunable" Surface (Streptavidin)
  • streptavidin modified polystyrene was used to link an oligonucleotide probe to the hybridization surface ofthe solid substrate.
  • the binding of biotinylated oligonucleotide probe is very tight (K approx. IO "15 M), and due to the paracrystalline nature of these surfaces, the probes may be precisely positioned at 50 Angstrom intervals (the physical separation of biotin binding sites on the streptavidin).
  • the streptavidin protein has a pK of about 5.5, thereby yielding an ionizable surface which can be modulated by subtle changes in the pH ofthe hybridization buffer solution.
  • the surface will be negatively charged; as the pH is lowered the charge on the streptavidin becomes more electroneutral to positive. It should also be noted that there is no effect on duplex formation in the range of pH 5 to 9 in solution.
  • Figures 4A, 4B, 5A and 5B illustrate the dramatic effect on the dissociation kinetics of matched and mismatched duplexes caused by changing the pH from neutrality to close to the pK value of streptavidin.
  • dissociation occurs in a mismatch specific manner and is sensitive to ionic strength conditions.
  • specific duplex formation can occur at the lower pH on streptavidin in distilled water where the surface is neutral to cationic.
  • FIGS 7A and 7B The results from this assay are shown in Figures 7A and 7B.
  • Figure 7A there is a two to three fold increase in binding ofthe target at lower ionic strengths (0 to 5 mM Na + ) than at the higher ionic strengths.
  • the binding shows ordinary dissociation kinetics indicating that the signal obtained is not due to non-specific adsorption of targets.
  • Figure 7B also indicates that there is excellent specificity even at equilibrium with regard to a mismatched probe.
  • Histidine is interesting in that its pK value is around 6.7. At pH values of around 8, its side chain charge is neutral. However, at pH 6.0 its side charge is a cation and assumes a formal positive charge. Therefore, if a negatively charged surface is modified with histidine or its methyl ester at a pH lower than 6.5, the surface will become positively charged, and become a general attractor for nucleic acid targets. If during washing the pH is raised to pH 8.0, the surface will become more negative and will electrostatically repel non-specifically bound targets. In this fashion, the surface acts as a hybridization rate enhancer and a discrimination enhancer during washing. This is, as mentioned, only one example of a potential surface which has even further interesting properties in addition to those already mentioned above. It is a good example of a switchable electrostatic surface useful in the present invention.
  • Salmine Al was used to assess the effect of protamine binding on the stability of matched versus mismatched base pairing.
  • Solution state binding equilibria were obtained by adding probe to the target solution (without biotin), or a probe homologue with base sequence changes. Duplex formation in solution consumes free target, thereby reducing the amount of target bound to the surface at equilibrium. By monitoring surface binding while performing a solution state probe titration, an accurate binding isotherm was obtained, to yield the association constant for duplex formation.
  • Salmine Al saturates at approximately 1000 fold lower ion concentrate than for Na + . Over the range from 30 nanomolar to 1 mM of added Salmine Al.
  • the solution state association constant for mismatched duplex formation is at least 1000-fold lower than for the perfectly matched 13 bp duplex.
  • the selectivity is sufficiently high that mismatched duplex formation cannot be detected experimentally at Salmine Al concentrations lower than 10 uM.
  • Synthetic peptides are synthesized in small quantities, first varying the nature ofthe kink or bend in the molecule, then the span ofthe oligo-arginine domain.
  • First generation peptides :
  • polystyrene can be coated with streptavidin.
  • Streptavidin forms a paracrystalline monolayer, with sites for biotin binding positioned 50 angstroms apart. Oligonucleotides are readily synthesized with a biotin group at the 3' terminus.
  • Streptavidin coated polystyrene was used as a prototype for the study of orderly surface films, to which probes can be affixed with spatial precision for the purpose of quantitative nucleic acid hybridization analysis.
  • Solution state nucleic acid targets were synthesized with digoxigenin (D) at the 3' terminus, so that duplex formation with probe oligomers on the streptavidin film support were monitored by anti-digoxigenin-AP chemiluminescence.
  • D digoxigenin
  • a 96 well microliter format was employed, assayed with an EGG robotic luminometer.
  • Samples were hybridized for 12 hours at 25°C and pH 7.2, which was sufficient to reach binding equilibrium.
  • Target concentration was held constant at 5xl0 "10 M (strands).
  • Probe density is fixed at 4x10 molecules per mm , which constitutes saturation ofthe available biotin binding sites (roughly 1 probe per 50 angstroms on center).
  • Fig. 10 Upon reducing bulk Na + concentrate to 10 mM, an abrupt 3 fold diminishment of target binding is detected (Fig. 10), indicative of a physical discontinuity in the binding process in the 10-20 mM range. Since streptavidin is negatively charged at pH 7.2, the paracrystalline streptavidin surface film must produce a negative surface potential. Standard Gouye-Debye theory predicts that this surface potential should decay exponentially, with a 1/e length near to 30 angstroms at 10 mM. Since that length is near to the separation between the surface film and the bound duplex, the Na + ion discontinuity detected below 20 mM is a direct result ofthe interaction between the surface field and the bound double helix.
  • Target controls which yield a doubly mismatched duplex do not yield measurable signals in this kinetic assay, therefore all signals in this kinetic assay are due to oligonucleotide-oligonucleotide binding.
  • the data show that the selectivity of duplex formation increases steadily with time, the ratio of matched versus mismatched target after a 180 min "wash" being 10 fold greater than at equilibrium. More fundamentally, the data suggest that at 5 mM Na + ion concentration and pH 7.2, the mean residence time ofthe duplex upon the surface has become dependant upon single base pair mismatches.
  • this kinetic distinction could be due to interaction within the double helix, or to the interaction ofthe helix with the surface field.
  • the streptavidin surface should become nearly uncharged, but the internal stability ofthe duplex should remain unaffected.
  • Figure 4B shows that surface neutralization has an enormous effect on duplex dissociation rate. The rates have become too slow to measure for both matched and mismatched duplexes upon the neutralized streptavidin surface.
  • the kinetic data therefore indicate that it is the electrostatic interaction with the surface, and not internal duplex electrostatics which dominate the kinetics of short duplex formation at pH 7 upon streptavidin coated polystyrene.
  • the electrostatic field near the solid support plays an active role in defining the affinity and selectivity of double helix formation in hybridization.
  • streptavidin model is not unique in this regard.
  • compositions are useful as hybridization surfaces. Examples of some useful compositions are shown in Table 1 and Figures 12 to 17.
  • This pK shift is studied by measuring the effect of bulk pH change on the affinity and kinetics of target binding to those surfaces in the range from pH 5 to 8. This effect is of importance in terms of basic hybridization technology.
  • Example 10 showed the activation of amines on the solid substrate.
  • Any ofthe chemistries 2-6 can be used for creating an amino acid combinatorial surface.
  • a plurality of amino acids can be attached to the surface.
  • R n,m can be any two different amino acids attached to the surface.
  • the surface can have several surface chemistries. There is a probe, a first amino acid, a second amino acid an unmodified carboxylic acid (Case 2 in Table 1) or unmodified linker chemistry (Case 2-6 in Table 1).
  • Salmine Al has no primary amines and a single carboxylate group at its C- terminus. Therefore, it can be linked, uniquely, by standard aqueous carboximide chemistry to a terminal group synthesized onto an oligonucleotide: Pro-SAL-Al-CONH-OLIGO.
  • the conjugate is linked to the surface by means of biotin coupling, using probes which bear biotin at the 3'- terminus, and a primary amine at the 5'- terminus for covalent coupling to the protamine.
  • “smart” surfaces may be used to considerable advantage with regard to the selectivity of duplex formation as well as by negating the effect of target secondary structure in solution.
  • substrate materials which are compatible with developing microelectronic detection devices (i.e., optically pure and sturdy).
  • Some examples of these substrate surfaces include quartz, Si0 2 , polystyrene, polypropylene and polyester.
  • streptavidin pH "tunable" surface was representative of only one of many possible chemical modifications which can be made using existing repertoires of surface chemistries.
  • the present invention has shown that there are developed methodologies to chemically modify a variety of surfaces in a combinatorial fashion, as well as instrumentation to insure high throughput for screening.
  • One skilled in the art readily recognizes that there are a variety of beneficial modifications.
  • Example 13 Hybridization rate enhancement with low ionic strength and low pH conditions
  • DNA microarray technology has recently become a valuable tool for the large-scale analysis of nucleic acids, e.g., in gene polymorphism and the analysis of gene expression at the mRNA level (see, e.g., Collins (1999) Nature Genetics Suppl. 21 :2).
  • modified nucleic acid probe chemistries e.g., peptide nucleic acids, PNAs
  • PNAs peptide nucleic acids
  • the invention provides a new method for the production and use of DNA microarrays.
  • the methods ofthe invention produce a major increase in hybridization rates between test sample nucleic acids (particularly high MW DNA) without the use of electric cu ⁇ ents; while at the same time allowing for duplex formation under low salt hybridization conditions, but with standard rather than modified DNA chemistries.
  • exemplary methods are, in part, based upon the invention's "tunable" hybridization surface, as described above.
  • This example uses the embodiment wherein a positive charge is induced onto the solid support surface or association surface (ofthe device ofthe invention) during the hybridization step.
  • the net cationic charge density ofthe device ofthe invention exploits weak, favorable adsorptive interactions with the negatively charged target DNA polyanion.
  • the solid support surface or association surface is induced to assume a net negative charge density during the wash step.
  • the nucleic acid duplexes formed during hybridization are then subject to unfavorable electrostatic (repulsive) interaction with the solid support surface or association surface ofthe device. This results in a significant increase in duplex selectivity in addition to an increase in the kinetics of association and disassociation.
  • the increase in duplex sensitivity can be equivalent to that seen if there had been an increase in temperature during washing.
  • Microa ⁇ ays were fabricated using biotin-modified oligonucleotide probes complexed with streptavidin (SA).
  • SA binds to the biotinylated probes, thus non-covalently attaching the probes to the solid support surface ofthe device ofthe invention.
  • streptavidin develops a positive charge (streptavidin has a pi of 5.5)
  • duplex formation becomes at least 80 fold faster than seen under standard conditions, where streptavidin is neutral or anionic.
  • Duplex formation becomes independent of solution state cation concentration in the low pH state, under conditions where specificity remains high.
  • positive device surface charge (net cationic charge density) during hybridization may be increasing the rate of duplex formation due to local concentration of target (e.g., DNA in a test sample) near the device surface (and the immobilized oligonucleotide probe). It may also cause an increase in the rate of unfolding of a partially structured or randomly coiled target (test sample) nucleic acid onto the charged probe-containing device surface.
  • a net negative surface charge on the device during the wash step may increase the stringency of duplex formation and/ or dissolution via a general decrease of duplex melting temperature due to proximity of a negative (repulsive) surface field.
  • the devices and methods ofthe invention can increase rates of hybridization and disassociation and increase stringency without the need to alter temperature (i.e., the device can be optimally operated and the methods ofthe invention practiced at room temperature).
  • Tunable surface DNA microarrays were fabricated by first modifying oligonucleotides with a terminal biotin. Biotinylated probes were then complexed in solution with a streptavidin tetramer at a 4/1 ratio of oligomer to tetramer. This protein-DNA complex was then printed directly onto clean polystyrene and allowed to link to the surface. The adsorptive interaction between SA and a neutral plastic surface is well-known, see, e.g., Shao (1992) Anal. Biochem. 205:77.
  • streptavidin was selected for this example because SA attached to a solid support (e.g., a neutral plastic surface) has a pi near 5.5. Therefore, SA is a highly anionic protein at neutral pH. However, SA can be driven into its cationic form below its pi of 5.5, e.g., at pH 5, while retaining its ability to bind biotin with high affinity. Equilibrium leading to nucleic acid duplex formation is not generally pH dependent in solution over the range from about pH 5 to about pH 9 (see, e.g., Sivasankax (1998) Proc. Natl. Acad. Sci. USA 95:12961-12966). Therefore, observed pH dependent effects in the range from about 5 to 9 can be linked to a change in surface charge due to ionization ofthe SA coated surface.
  • microa ⁇ ays polystyrene in a standard 96-well format (Coming) with raised circular wells was employed.
  • Microa ⁇ ays were printed with a Hamilton Micro Lab 2200TM robot (Hamilton Instruments). The robot deposited 25 nL of a mixture of SA (2 ⁇ M) and biotin-modified oligonucleotide probes (8 ⁇ M) in 20 mM NaOAc at pH 5.5 per array spot element. Each a ⁇ ay had 14 elements, representing 7 capture oligonucleotides printed in duplicate. Subsequent to printing, a ⁇ ays were incubated overnight at RT in a humidity chamber to allow the stable adsorption of SA upon the underlying polystyrene substrate.
  • oligonucleotides complementary to codon 12 mutations were designed to serve as capture probes on the a ⁇ ay, with the following sequences: Kl: 5'- gacctggtggcg-3' ; K2: 5'-gacctagtggcg-3' ; K3: 5'-gacttggtggcg-3' ; K4: 5'-gacctcgtggcg-3' ; K5: 5'-gacctgatggcg-3' ; K6: 5'-gacctgctggcg-3' ; K7: 5'-gacctgttggcg-3' .
  • K-ras amplicons were amplified by the polymerase chain reaction, PCR.
  • the PCR protocol was the following: one pre-PCR cycle 94°C for 12 min, 60°C for 1 min, and 72°C for 1 min; 35 PCR cycles 95°C for 1 min, 57°C for 1 min, 72°C for 1 min; hold cycle 72°C for 7 min, hold at 4°C.
  • PCR primers (Midland Certified Reagent Co.) for k-ras amplicons were labeled with digoxigenin at their 5' ends during synthesis and had the following sequences: 5'-dig- actgaatataaacttgtggtagttggacct-3' and 5'-dig-tcaaagaatggtcctgcacc -3'.
  • test sample The kinetics of target k-ras amplicon (the "test sample") hybridization to the probe (immobilized to the SA surface of the device ofthe invention) under "standard” high salt, high pH conditions was compared to hybridization under low salt, low pH conditions.
  • High salt, high pH prehybridization solution contained 150 mM sodium citrate (in respect to sodium ion concentration), 5X Denhardt's solution, pH 8.0. This was applied to the a ⁇ ay for at least 10 minutes. It was vacuumed off and high salt, high pH hybridization solution (1 nM amplicon, 0.1 ⁇ M chaperone, 150 mM sodium citrate in respect to sodium, 5X Denhardt's solution, pH 8.0) was applied to the array. After hybridization, the array was washed two times in 100 mM sodium citrate with respect to sodium 10 minutes each, pH 7.8, followed by a brief rinse in lXSSC.
  • Low salt, low pH prehybridization solution contained 0.2 % Tween 20 in 5X Denhardt's solution. It was applied to the a ⁇ ay for at least 10 minutes. It was vacuumed off and low salt, low pH hybridization solution (1 nM of amplicon in 2 mM sodium phosphate, containing 0.1 % Tween 20 at pH 5.0) was applied to the array. After hybridization, the array was washed once in 100 mM sodium phosphate, pH 7.8 for 10 minutes, followed by a brief rinse in lXSSC.
  • the digoxigenin-labeled amplicon was detected using anti-digoxigenin antibody linked to alkaline phosphatase (Boehringer Mannheim) and by an enzyme linked fluorescent substrate (ELF, Molecular Probes Inc., Eugene, OR) for alkaline phosphatase as described by R.P. Haugland, Handbook of Fluorescent Probes and Research Chemicals; Molecular Probes, Inc., ed. 6, 1996, pp.117-120.
  • the anti-digoxigenin antibody was used at 1 : 1000 dilution in the blocking buffer from the ELF-97 mRNA In Situ Hybridization KitTM
  • Figure 18A shows data demonstrating the slow kinetics of k-ras 1 amplicon hybridization at high salt and high pH conditions.
  • Solid lines represent a probe with a perfect base pair match (kl probe, above).
  • Open lines represent a probe with a single base pair (a G- T) mismatch (the k3 probe); hybridization signals indistinguishable from background. All other single base pair mismatches (i.e., GA, GG, CC, CT, TC) gave hybridization signals which also were indistinguishable from background.
  • Figure 18B shows data demonstrating the fast kinetics of k-ras amplicon hybridization at low salt and low pH conditions.
  • Solid lines represent perfectly matched base pair of probe to k-ras target (kl probe).
  • Open lines represent probes with a single G-T mismatch (k3 probe); hybridization signals indistinguishable from background. All other mismatches (i.e., GA, GG, CC, CT, TC) gave hybridization signals which also were indistinguishable from background.
  • hybridization kinetics for a 1 nM solution ofthe wild type (WT) k-ras amplicon approximate a simple exponential rise to equilibrium, with a half time of approximately 40 minutes at standard high salt, high pH conditions (Fig. 18 A) and less than 30 seconds for low salt, low pH condition (Fig. 18B).
  • the observed hybridization rate enhancement was at least 80 fold.
  • hybridization was found to be nearly instantaneous (relative to a 30 second time resolution of the fluid delivery system ofthe device).
  • washing could be reduced to as little as 30 seconds.
  • hybridization and washing can be completed in less than one minute.
  • Rate enhancement effect and high sequence selectivity by the methods and devices ofthe invention has also been observed in real kinetic time via the label free surface plasmon resonance technique. Rate enhancement effect and high sequence selectivity was observed using the surface and k-ras amplicon target model described above, as well as for other target-probe models which do not require a chaperone (e.g., the rat Neu amplicon). This demonstrates that the observed hybridization enhancement is a general property ofthe interaction between DNA and immobilized probes on the invention's device surfaces (including embodiments comprising adjustable, or "tunable," device surface charge).
  • the present invention provides new and novel benefits including providing teachings to modify the surface to enhance hybridization selectivity, sensitivity and discrimination power.
  • Surface physical chemistry can be modified to play a significant role in duplex formation at surfaces, particularly with regard to ionic strength dependence.
  • the participation ofthe surface in the binding reaction is exploitable by the use of active chemical modifications.
  • additional modifications can be rapidly searched by using combinatorial means.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

L'invention concerne des dispositifs et des procédés permettant l'association et la liaison améliorées et sélectives entre des matériaux biologiques, tels que des acides nucléiques, par exemple, l'ADN ou l'ARN, ou des polypeptides, et une sonde oligonucléotidiques immobilisées. Dans un mode de réalisation, l'invention concerne un dispositif d'association comprenant un pluralité de sondes d'acides nucléiques ou de sondes de polypeptides ou une combinaison de ces sondes reliées à un substrat solide; ce substrat solide comprend une surface de substrat comprenant un surface de substrat extérieure et une pluralité de pores intérieurs, ces pores comprenant une ouverture d'extrémité proximale à la surface extérieures permettant le passage de fluide dans un pore, les surfaces des pores comprenant une surface d'association. Cette surface d'association comprend une surface chargée possédant une charge globale de densité positive (cationique) dans des conditions renfermant un pH inférieur au pI de la surface d'association. L'invention concerne également des procédés de fabrication de ces dispositifs d'hybridation et d'association. Par exemple, les dispositifs et les procédés selon l'invention peuvent être utilisés dans des tests diagnostiques à base d'acide nucléique ou pour la détection de l'association d'un acide nucléique dans un échantillon avec une sonde d'acide nucléique ou pour la purification d'un acide nucléique à partir d'un échantillon.
PCT/US2000/023438 2000-03-09 2000-08-24 Dispositifs monoblocs d'hybridation d'acide nucleique WO2001066687A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2000269393A AU2000269393A1 (en) 2000-03-09 2000-08-24 Integrated nucleic acid hybridization devices

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US52224000A 2000-03-09 2000-03-09
US09/522,240 2000-03-09
US63626800A 2000-08-10 2000-08-10
US09/636,268 2000-08-10

Publications (1)

Publication Number Publication Date
WO2001066687A1 true WO2001066687A1 (fr) 2001-09-13

Family

ID=27060753

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/023438 WO2001066687A1 (fr) 2000-03-09 2000-08-24 Dispositifs monoblocs d'hybridation d'acide nucleique

Country Status (2)

Country Link
AU (1) AU2000269393A1 (fr)
WO (1) WO2001066687A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1393073A2 (fr) * 2001-05-03 2004-03-03 Sigma-Genosys, Ltd. Procede d'assemblage de microreseaux de proteines
EP1426470A1 (fr) * 2002-12-03 2004-06-09 Motorola, Inc. Liaison de carbon nanomorphique avec acides nucléiques
US7195872B2 (en) 2001-11-09 2007-03-27 3D Biosurfaces, Inc. High surface area substrates for microarrays and methods to make same
EP1908829A1 (fr) * 2005-07-27 2008-04-09 National Institute of Advanced Industrial Science and Technology Sonde oligonucleotidique
US8951719B2 (en) 2008-09-12 2015-02-10 Gentegra, LLC. Matrices and media for storage and stabilization of biomolecules
CN108130600A (zh) * 2017-12-20 2018-06-08 栾图 用于转基因成分富集提取的基因芯片及其制备方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997018226A1 (fr) * 1995-11-14 1997-05-22 Baylor College Of Medicine Dispositifs integres d'hybridation d'acides nucleiques dont la fonction est fondee sur la chimie des surfaces actives
US5667667A (en) * 1992-04-24 1997-09-16 Isis Innovation Limited Electrochemical treatment of surfaces
US5763175A (en) * 1995-11-17 1998-06-09 Lynx Therapeutics, Inc. Simultaneous sequencing of tagged polynucleotides
US5780231A (en) * 1995-11-17 1998-07-14 Lynx Therapeutics, Inc. DNA extension and analysis with rolling primers
US5962228A (en) * 1995-11-17 1999-10-05 Lynx Therapeutics, Inc. DNA extension and analysis with rolling primers
US6103463A (en) * 1992-02-19 2000-08-15 The Public Health Research Institute Of The City Of New York, Inc. Method of sorting a mixture of nucleic acid strands on a binary array

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103463A (en) * 1992-02-19 2000-08-15 The Public Health Research Institute Of The City Of New York, Inc. Method of sorting a mixture of nucleic acid strands on a binary array
US5667667A (en) * 1992-04-24 1997-09-16 Isis Innovation Limited Electrochemical treatment of surfaces
WO1997018226A1 (fr) * 1995-11-14 1997-05-22 Baylor College Of Medicine Dispositifs integres d'hybridation d'acides nucleiques dont la fonction est fondee sur la chimie des surfaces actives
US5763175A (en) * 1995-11-17 1998-06-09 Lynx Therapeutics, Inc. Simultaneous sequencing of tagged polynucleotides
US5780231A (en) * 1995-11-17 1998-07-14 Lynx Therapeutics, Inc. DNA extension and analysis with rolling primers
US5962228A (en) * 1995-11-17 1999-10-05 Lynx Therapeutics, Inc. DNA extension and analysis with rolling primers

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1393073A2 (fr) * 2001-05-03 2004-03-03 Sigma-Genosys, Ltd. Procede d'assemblage de microreseaux de proteines
EP1393073A4 (fr) * 2001-05-03 2007-03-28 Sigma Genosys Ltd Procede d'assemblage de microreseaux de proteines
US7195872B2 (en) 2001-11-09 2007-03-27 3D Biosurfaces, Inc. High surface area substrates for microarrays and methods to make same
EP1426470A1 (fr) * 2002-12-03 2004-06-09 Motorola, Inc. Liaison de carbon nanomorphique avec acides nucléiques
WO2004050967A1 (fr) * 2002-12-03 2004-06-17 Motorola Inc Liaison de carbone nanomorphe a un acide nucleique
EP1908829A1 (fr) * 2005-07-27 2008-04-09 National Institute of Advanced Industrial Science and Technology Sonde oligonucleotidique
EP1908829A4 (fr) * 2005-07-27 2009-03-04 Nat Inst Of Advanced Ind Scien Sonde oligonucleotidique
US8951719B2 (en) 2008-09-12 2015-02-10 Gentegra, LLC. Matrices and media for storage and stabilization of biomolecules
US10160997B2 (en) 2008-09-12 2018-12-25 Gentegra Llc Matrices and media for storage and stabilization of biomolecules
CN108130600A (zh) * 2017-12-20 2018-06-08 栾图 用于转基因成分富集提取的基因芯片及其制备方法

Also Published As

Publication number Publication date
AU2000269393A1 (en) 2001-09-17

Similar Documents

Publication Publication Date Title
US6245518B1 (en) Polynucleotide arrays and methods of making and using the same
EP3020831B1 (fr) Procédés d'amplification basée à la helicase et de détection de polynucléotides
US8685894B2 (en) Modified nucleic acid nanoarrays and uses therefor
US20080187912A1 (en) Oligonucleotide arrays for high resolution HLA typing
US20100167295A1 (en) Methods for haplotyping genomic dna
US20030055233A1 (en) Gradient resolved information platform
JP3883539B2 (ja) エポキシ基を有する放射状ポリエチレングリコール誘導体を用いたハイドロゲルバイオチップの製造方法
WO2001006011A2 (fr) Matrices comprenant des sondes d'acides nucleiques associes de maniere non covalente, et procedes associes de fabrication et d'utilisation
US9266726B2 (en) Method for making biochips
US6905829B2 (en) Method for detecting hybridized nucleic acid with improved sensitivity
EP0910570A1 (fr) Dispositifs integres d'hybridation d'acides nucleiques dont la fonction est fondee sur la chimie des surfaces actives
WO2001066687A1 (fr) Dispositifs monoblocs d'hybridation d'acide nucleique
US7049073B2 (en) Double stranded nucleic acid biochips
US20030211496A1 (en) Quality control reagents for nucleic acid microarrays
KR100580644B1 (ko) 생물분자를 고체 기판상에 비공유적으로 고정화 하는 방법및 그에 의하여 제조되는 마이크로어레이
US20020172960A1 (en) DNA microarrays of networked oligonucleotides
EP1649060A1 (fr) Analyse d'expression d'arnm
CN1147592C (zh) 荧光共振能量转移类寡核苷酸基因芯片制备方法
Cansız Development of a sandwich-type dna array platform for the detection of label-free oligonucleotide targets

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载